Literature DB >> 27713670

Calprotectin: Clinical Applications in Pediatrics.

Oscar R Herrera1, Michael L Christensen2, Richard A Helms2.   

Abstract

As seen over the past 20 years, calprotectin has evolved as a novel, non-invasive biomarker of gastrointestinal (GI) inflammation. We present this review of calprotectin in pediatrics. This article will focus on studies using calprotectin concentrations from different body fluids to monitor inflammation in different disease states and conditions. The ultimate goal of our group is to lay down a foundation as we consider using calprotectin prospectively as a marker of intestinal inflammation that could lead to further testing and possibly a marker of preparedness for feeding. We surveyed all published studies in English of calprotectin in neonates, infants, children, and adolescents through February 2014. We will discuss calprotectin's basic properties and analysis such as characteristics, identification, presence in body fluids, and maturational development. In addition, calprotectin's use in inflammatory diseases exploring both GI and non-GI conditions will be evaluated and compared with other serum markers presently available. Finally, a summary of our findings and discussion of future work that could be undertaken in order to render calprotectin as a more useful monitoring tool to the medical research community will complete the review.

Entities:  

Keywords:  biomarker; inflammation; leukocyte L1 antigen complex; pediatric

Year:  2016        PMID: 27713670      PMCID: PMC5040174          DOI: 10.5863/1551-6776-21.4.308

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN: 1551-6776


  101 in total

1.  Expression of myeloid-related protein-8 and -14 in patients with acute Kawasaki disease.

Authors:  Keiich Hirono; Dirk Foell; Yanlin Xing; Sachiko Miyagawa-Tomita; Fei Ye; Martina Ahlmann; Thomas Vogl; Takeshi Futatani; Chen Rui; Xianyi Yu; Kazuhiro Watanabe; Sayaka Wanatabe; Shinichi Tsubata; Keiichiro Uese; Ikuo Hashimoto; Fukiko Ichida; Makoto Nakazawa; Johannes Roth; Toshio Miyawaki
Journal:  J Am Coll Cardiol       Date:  2006-08-28       Impact factor: 24.094

2.  The crystal structure of the human (S100A8/S100A9)2 heterotetramer, calprotectin, illustrates how conformational changes of interacting alpha-helices can determine specific association of two EF-hand proteins.

Authors:  Ingo P Korndörfer; Florian Brueckner; Arne Skerra
Journal:  J Mol Biol       Date:  2007-05-03       Impact factor: 5.469

3.  Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin.

Authors:  M Steinbakk; C F Naess-Andresen; E Lingaas; I Dale; P Brandtzaeg; M K Fagerhol
Journal:  Lancet       Date:  1990-09-29       Impact factor: 79.321

4.  Serum intestinal fatty acid binding protein level for early diagnosis and prediction of severity of necrotizing enterocolitis.

Authors:  Cumhur Aydemir; Dilek Dilli; Serife Suna Oguz; Hulya Ozkan Ulu; Nurdan Uras; Omer Erdeve; Ugur Dilmen
Journal:  Early Hum Dev       Date:  2011-06-08       Impact factor: 2.079

5.  Serum and urinary concentrations of calprotectin as markers of insulin resistance and type 2 diabetes.

Authors:  Francisco J Ortega; Mónica Sabater; José M Moreno-Navarrete; Neus Pueyo; Patricia Botas; Elias Delgado; Wifredo Ricart; Gema Frühbeck; José Manuel Fernández-Real
Journal:  Eur J Endocrinol       Date:  2012-07-20       Impact factor: 6.664

6.  Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.

Authors:  Kaija-Leena Kolho; Taneli Raivio; Harry Lindahl; Erkki Savilahti
Journal:  Scand J Gastroenterol       Date:  2006-06       Impact factor: 2.423

Review 7.  Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 3: Super calprotectin will not expedite your discharge.

Authors:  Daniel Horner; Anna-May Long
Journal:  Emerg Med J       Date:  2013-08       Impact factor: 2.740

8.  Plasma calprotectin in chronically dialyzed end-stage renal disease patients.

Authors:  Karin Malícková; Helena Brodská; Jana Lachmanová; Sylvie Dusilová Sulková; Ivana Janatková; Helena Marecková; Vladimír Tesar; Tomás Zima
Journal:  Inflamm Res       Date:  2009-10-25       Impact factor: 4.575

9.  Serum calprotectin: an antimicrobial peptide as a new marker for the diagnosis of sepsis in very low birth weight newborns.

Authors:  Gianluca Terrin; Annalisa Passariello; Francesco Manguso; Gennaro Salvia; Luciano Rapacciuolo; Francesco Messina; Francesco Raimondi; Roberto Berni Canani
Journal:  Clin Dev Immunol       Date:  2011-05-30

10.  Can Fecal Calprotectin Level Be Used as a Markers of Inflammation in the Diagnosis and Follow-Up of Cow's Milk Protein Allergy?

Authors:  Omer F Beşer; Selim Sancak; Tülay Erkan; Tufan Kutlu; Haluk Cokuğraş; Fügen Ç Cokuğraş
Journal:  Allergy Asthma Immunol Res       Date:  2013-11-08       Impact factor: 5.764

View more
  12 in total

1.  Combinatorial Omics Analysis Reveals Perturbed Lysosomal Homeostasis in Collagen VII-deficient Keratinocytes.

Authors:  Kerstin Thriene; Björn Andreas Grüning; Olivier Bornert; Anika Erxleben; Juna Leppert; Ioannis Athanasiou; Ekkehard Weber; Dimitra Kiritsi; Alexander Nyström; Thomas Reinheckel; Rolf Backofen; Cristina Has; Leena Bruckner-Tuderman; Jörn Dengjel
Journal:  Mol Cell Proteomics       Date:  2018-01-11       Impact factor: 5.911

2.  Implications of hepatic dysfunction in Kawasaki disease: Time-related changes in aspartate aminotransferase, alanine aminotransferase, total bilirubin, and C-reactive protein levels.

Authors:  Yasuhiko Tomita; Takashi Fukaya; Yasuko Yamaura; Rie Tsujiguchi; Haruko Muratani; Maki Shimaya
Journal:  Pediatr Investig       Date:  2019-03-22

Review 3.  Current status of fecal calprotectin as a diagnostic or monitoring biomarker for cow's milk protein allergy in children: a scoping review.

Authors:  Li-Jing Xiong; Xiao-Li Xie; Yang Li; Xiao-Zhi Deng
Journal:  World J Pediatr       Date:  2020-05-11       Impact factor: 2.764

4.  Effects of herbal nutraceuticals and/or zinc against Haemonchus contortus in lambs experimentally infected.

Authors:  Zora Váradyová; Dominika Mravčáková; Michal Babják; Magdalena Bryszak; Ľubomíra Grešáková; Klaudia Čobanová; Svetlana Kišidayová; Iveta Plachá; Alžbeta Königová; Adam Cieslak; Sylwester Slusarczyk; Lukasz Pecio; Mariusz Kowalczyk; Marián Várady
Journal:  BMC Vet Res       Date:  2018-03-09       Impact factor: 2.741

5.  Natural chemotherapeutic alternatives for controlling of haemonchosis in sheep.

Authors:  Dominika Mravčáková; Zora Váradyová; Anna Kopčáková; Klaudia Čobanová; Ľubomíra Grešáková; Svetlana Kišidayová; Michal Babják; Michaela Urda Dolinská; Emília Dvorožňáková; Alžbeta Königová; Jaroslav Vadlejch; Adam Cieslak; Sylwester Ślusarczyk; Marián Várady
Journal:  BMC Vet Res       Date:  2019-08-20       Impact factor: 2.741

6.  Comparison of a rapid test and an automated method for faecal calprotectin measurement.

Authors:  Sandra Martins; David Garcia; Rui Farinha; João Tiago Guimarães
Journal:  Pract Lab Med       Date:  2019-09-19

7.  Gastrointestinal manifestations and their relation to faecal calprotectin in children with autism.

Authors:  Hanan Galal Azouz; Nermine Hossam El-Din Zakaria; Ahmed Fouad Khalil; Sara Mohammad Naguib; Mona Khalil
Journal:  Prz Gastroenterol       Date:  2021-12-02

8.  Normal fecal calprotectin levels in healthy children are higher than in adults and decrease with age.

Authors:  Marta Velasco Rodríguez-Belvís; Javier Francisco Viada Bris; Carmen Plata Fernández; Alberto García-Salido; Julia Asensio Antón; Gloria Domínguez Ortega; Rosa Ana Muñoz Codoceo
Journal:  Paediatr Child Health       Date:  2019-06-17       Impact factor: 2.253

9.  Diagnostic Accuracy of Serum and Urine S100A8/A9 and Serum Amyloid A in Probable Acute Abdominal Pain at Emergency Department.

Authors:  Arash Forouzan; Kambiz Masoumi; Fakher Rahim; Meisam Moezzi; Ali Khavanin; Nastaran Ranjbari; Malehi Amal Saki; Amirali Fallah Amoli; Niloofar Akhiani; Fatemeh Ghourchian
Journal:  Dis Markers       Date:  2018-07-03       Impact factor: 3.434

10.  Effects of unsaturated fatty acids (Arachidonic/Oleic Acids) on stability and structural properties of Calprotectin using molecular docking and molecular dynamics simulation approach.

Authors:  Nematollah Gheibi; Mohamad Ghorbani; Hanifeh Shariatifar; Alireza Farasat
Journal:  PLoS One       Date:  2020-03-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.